大脳線条体経路におけるThy1の喪失は大脳線条体経路におけるドパミンおよびガバペンチンへの応答を変化させる
Cezar Goletiani1,2,3, Matthew D McEchron4, Elizabeth Neely3
1Institute of Cognitive Neurosciences, Free University of Tbilisi, Tbilisi, Georgia.
Abstract:
Thy1, a synaptic protein, may support synaptic junction adherence. Thus, we hypothesized that loss of Thy1 may alter synaptic transmission. Our focus on the Thy1 knockout (KO) mouse model stems from the loss of Thy1 expression in individuals with Restless Legs Syndrome (RLS), a neurological disorder. This investigation aimed to determine: 1) if the absence of Thy1 affects synaptic function in the striatal region, 2) if the absence of Thy1 alters the synaptic response to dopamine and gabapentin, and 3) if the Thy1 loss can alter behavior modulated by the striatum. Network-level synaptic transmission was measured in corticostriatal slices from Thy1 KO and C57BL/6 control mice. In vivo, acoustic startle behavioral testing was used to measure startle reaction and prepulse inhibition in both groups. Raclopride, a D2 receptor antagonist, decreased population spike amplitude in control but not Thy1 KO slices. Quinpirole, a D2 receptor agonist, did not change spike amplitude in any group. Gabapentin, a Ca2+ channel blocker, reduced population spike amplitude in Thy1 KO slices more than in controls. The behavioral acoustic startle response was diminished in Thy1 KO mice and attributed to enhanced prepulse inhibition. Loss of Thy1 alters striatal synaptic function, affecting dopaminergic modulation of corticostriatal neurotransmission and resulting in disruption of the startle response and prepulse inhibition.
さらに関連する動画
04:05Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
Published on: October 6, 2023
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
関連する概念動画
Drugs Affecting Neurotransmitter Synthesis
Desensitization and Tachyphylaxis
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
